
of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which
当前文章:http://5oad.mubolai.cn/dippq2/lfl2ryo.html
发布时间:04:12:51
仙工智能港股IPO获中国证监会备案
不满马奎尔落选!家人怒斥:简直恶心;这辈子见过最糟糕的决定
世体:姆巴佩预计进入国家德比名单,但能否出战仍存疑
政声直达|唐山连续6年入选全国城市体检样本城市
澳大利亚防守稳固!浮嶋敏:我们不是非常忌惮,会做好分析
前4个月,粤港澳大湾区内地9市进出口同比增长18.4%